Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Osteoporos Int. 2014 Nov 15;26(2):673–679. doi: 10.1007/s00198-014-2927-7

Table 1.

Cohort characteristics, mean ± SD

DM2
n=22
Non-DM2
n=78
p-value (t-test or chi-square)
Age, yr 60.1 ± 2.8 59.4 ± 2.5 0.26
Weight, kg 87 ± 20 84 ± 19 0.58
BMI, kg/m2 32 ± 7 31 ± 7 0.58
Time since menopause, yr 8.7 ± 2.9 7.7 ± 3.7 0.28
Previous fracture, N (%) 4 (18%) 5 (6%) 0.10
Current smoking, N (%) 8 (36%) 10 (13%) 0.02
Current alcohol ≥1 drink/day, N (%) 14 (64%) 50 (64%) 0.20
Physical activity score* 7.2 ± 2.1 7.8 ± 1.8 0.18
Osteoporosis medication, N (%) 8 (36%) 29 (37%) 1.00
Glucocorticoid medication, N (%) 4 (18%) 9 (12%) 0.47
Fasting glucose, mg/dL 115 ± 41 91 ± 12 0.02
Fasting insulin, uIU/mL 23 ± 29 14 ± 17 0.11
HOMA-IR 6.3 ± 7.4 3.5 ± 6.6 0.11
Spine BMD, g/cm2 1.079 ± 0.220 1.061 ± 0.155 0.67
Total hip BMD, g/cm2 1.019 ± 0.172 1.002 ± 0.144 0.64
Femoral neck BMD, g/cm2 0.896 ± 0.130 0.873 ± 0.144 0.51
Total body BMD, g/cm2 1.170 ± 0.120 1.154 ± 0.126 0.60
*

Scores range 3–9 with higher scores indicating increased physical activity(12)